Open access
850
Views
0
CrossRef citations to date
0
Altmetric
Brief Report
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
Andreas Pintera Department of Dermatology, Venereology and Allergology, University Hospital Frankfurt, Frankfurt am Main, GermanyView further author information
, Kilian Eyerichb Department of Dermatology and Venerology, Medical Center, University of Freiburg, Freiburg im Breisgau, Germany;c Karolinska Institutet and Karolinska University Hospital, Stockholm, SwedenView further author information
, Antonio Costanzod Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy;e Dermatology, Humanitas Research Hospital IRCCS, Rozzano, Milan, ItalyView further author information
, Alyssa Garreltsf Eli Lilly and Company, Indianapolis, Indiana, USAView further author information
, Christopher Schusterf Eli Lilly and Company, Indianapolis, Indiana, USA;g Department of Dermatology, Medical University of Vienna, Vienna, AustriaView further author information
, Can Merth HaaPACS GmbH, Schriesheim, GermanyView further author information
, Anastasia Lampropoulouf Eli Lilly and Company, Indianapolis, Indiana, USAView further author information
, Konstantinos Fotiouf Eli Lilly and Company, Indianapolis, Indiana, USAView further author information
, Julia-Tatjana Mauli Department of Dermatology, University Hospital Zurich, Zurich, Switzerland;j Faculty of Medicine, University of Zürich, Zurich, SwitzerlandView further author information
& Kim A. Pappk Alliance Clinical Trials and Probity Medical Research, Waterloo, Ontario, Canada;l Division of Dermatology, Department of Medicine, University of Toronto, Ontario, CanadaCorrespondence[email protected]
https://orcid.org/0000-0001-9557-3642View further author information
show allhttps://orcid.org/0000-0001-9557-3642View further author information
Article: 2350227
|
Received 29 Feb 2024, Accepted 24 Apr 2024, Published online: 26 May 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.